Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques

Biochem Biophys Res Commun. 2004 Oct 22;323(3):898-905. doi: 10.1016/j.bbrc.2004.08.178.

Abstract

Genes induced or suppressed by oxidized low-density lipoproteins (oxLDL) in human monocytic THP-1 cells were searched using the differential display reverse transcriptase polymerase chain reaction. One of the differentially expressed (up-regulated) cDNA fragments was found to contain sequences corresponding to monocyte chemotactic protein-3 (MCP-3). The stimulatory effect of the oxLDL on the expression of MCP-3 mRNA was both time- and dose-dependent. Treatment with GF109203X and genistein, inhibitors of protein kinase C and tyrosine kinase, respectively, had no effect on the induction of MCP-3 mRNA by oxLDL, while treatment with cycloheximide inhibited the induction. The induction was reproduced by the lipid components in oxLDL such as 9-HODE and 13-HODE, which are known to activate the peroxisome proliferator-activated receptor gamma (PPARgamma). Introduction of an endogenous PPARgamma ligand, 15d-PGJ2, in the culture of THP-1 cells resulted in the induction of MCP-3 gene expression. Furthermore, analyses of human atherosclerotic plaques revealed that the expressional pattern of MCP-3 in the regions of neointimal and necrotic core overlapped with that of PPARgamma. These results suggest that oxLDL delivers its signal for MCP-3 expression via PPARgamma, which may be further related to the atherogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotid Arteries / drug effects
  • Carotid Arteries / metabolism
  • Carotid Arteries / pathology
  • Chemokine CCL7
  • Coronary Artery Disease / metabolism*
  • Coronary Artery Disease / pathology*
  • Cytokines / metabolism*
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Humans
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, LDL / pharmacology*
  • Monocyte Chemoattractant Proteins / metabolism*
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • Monocytes / pathology*
  • Oxidation-Reduction
  • Tissue Distribution
  • U937 Cells

Substances

  • CCL7 protein, human
  • Chemokine CCL7
  • Cytokines
  • Lipoproteins, LDL
  • Monocyte Chemoattractant Proteins